About the Congress
|DDDN is a comprehensive Congress fully devoted to neurotherapeutic topics. DDDN is aimed at interaction between medical specialists, neuroscientists and the industry.
International renowned opinion leaders will discuss current issues on Stroke, Alzheimer's Disease, MS, and other fields in Neurology. The unique concept of this congress allows ample time for speaker-participant interaction.
Deadline for Late Fees:
August 19, 2014
Save the dates for the
2nd DDDN Congress:
September 3-6, 2015
Prague, Czech Republic
MANAGEMENT DILEMMAS IN MS
Debate: Life risking' therapy in MS: Where should we draw a line?
Only rarely: H.P. Hartung, Germany
More than today: I. Steiner, Israel
DISEASE MODIFYING DRUGS FOR MULTIPLE SCLEROSIS: HOW SHOULD WE MONITOR TREATMENT RESPONSE?
Debate: The end points in MS disease evaluation
Should be clinical disability: A. Pachner, USA
Should be relapse rate: H.P. Hartung, Germany
Should be imaging: D.L. Arnold, Canada
Welcome to DDDN
Dear Colleagues, we are pleased to announce the World Congress on Neuro-Therapeutics: Dilemmas, Debates & Discussions (DDDN) will be held in Basel, Switzerland, September 4-7, 2014. This ‘concept meeting’ will focus on therapeutic issues of neurological diseases.
|Zohar Argov||Israel Steiner|